Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis
Author(s) -
Mikhail M. Kostik,
M. F. Dubko,
L. S. Snegireva,
V.V. Masalova,
T.L. Kornishina,
Tatyana Likhacheva,
И. А. Чикова,
E.A. Isupova,
Ekaterina Kuchinskaya,
Natalia I Glebova,
O. V. Kalashnikova,
V. G. Chasnykh
Publication year - 2013
Publication title -
вопросы современной педиатрии
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v12i5.793
Subject(s) - tocilizumab , medicine , discontinuation , macrophage activation syndrome , arthritis , juvenile , surgery , pediatrics , rheumatoid arthritis , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom